Response to “In vivo secretion of anti-CD3 × anti-tumor bispecific antibodies by gene-modified cells: over a decade of T-cell engagement”

פריטים דומים

• In vivo secretion of anti-CD3 × anti-tumor bispecific antibodies by gene-modified cells: over a decade of T-cell engagement
  מאת: Compte, Marta, et al.
  יצא לאור: (2015)
• Human endoglin-CD3 bispecific T cell engager antibody induces anti-tumor effect in vivo
  מאת: Zhong, Liping, et al.
  יצא לאור: (2021)
• Antitumor activity of T cells secreting αCD133-αCD3 bispecific T-cell engager against cholangiocarcinoma.
  מאת: Thanich Sangsuwannukul, et al.
  יצא לאור: (2022-01-01)
• Early cytokine and chemokine signals shape the anti-AML activity of bispecific engager-secreting T cells
  מאת: Natalie J. Holl, et al.
  יצא לאור: (2025-09-01)
• Costimulatory T cell engagement via a novel bispecific anti-CD137 /anti-HER2 protein
  מאת: Hinner, Marlon J, et al.
  יצא לאור: (2015)